SAB Biotherapeutics (SABS) Long-Term Debt Issuances (2020 - 2021)
SAB Biotherapeutics (SABS) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $150000.0 as the latest value for Q1 2021.
SAB Biotherapeutics (SABS) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $150000.0 as the latest value for Q1 2021.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month